세계의 중요 장기 지원 시스템 및 의료 바이오닉스 시장 규모 : 제품별, 최종 사용자별, 지역별, 범위 및 예측
Global Vital Organs Support Systems And Medical Bionics Market Size By Product (Vital Organs Support Systems, Medical Bionics), By End-User (Hospitals, Ambulatory Surgical Centers), By Geographic Scope And Forecast
상품코드:1622100
리서치사:Verified Market Research
발행일:2024년 11월
페이지 정보:영문 202 Pages
라이선스 & 가격 (부가세 별도)
한글목차
중요 장기 지원 시스템 및 의료 바이오닉스 시장 규모 및 예측
중요 장기 지원 시스템 및 의료 바이오닉스 시장 규모는 2024년 464억 3,000만 달러로 평가되었고, 2024년부터 2031년까지 연평균 복합 성장률(CAGR) 9.60%로 성장하여 2031년에는 966억 6,000만 달러에 달할 것으로 예측되고 있습니다. 평가 보고서는 세계의 주요 장기 지원 시스템 및 의료 바이오닉스 시장을 종합적으로 평가하고 분석했습니다.
세계 주요 장기 지원 시스템 및 의료 바이오닉스 시장 정의
장기 지원 시스템을 구성하는 인공 장기는 인간의 자연적인 장기 기능을 모방하여 만들어져 결손 또는 손상된 장기의 대체나 이미 기능하고 있는 장기의 서포트에 사용됩니다. 생체 조직에 연결되어 누락 된 인간 장기의 대안입니다.
생체와 특정 생체 부분을 복제하는 기계 시스템의 연구는 의료 바이오닉스로 알려져 있습니다. 위험을 완화하고 다양한 질병에 대한보다 저렴한 치료 옵션을 제공하는 이점이 있습니다.
장기 지원 시스템 및 의료 바이오닉스 세계 시장 개요
최근 중요한 장기 지원 시스템과 의료 바이오닉스 세계 시장은 상당한 확대를 경험하고 있으며, 앞으로도 점유율과 금액 양면에서 크게 확대될 것으로 예상됩니다. 이 배경에는 장기 제공업체 부족, 장기 이식 사례 증가, 유전 장애 및 사고로 인한 장애로 장기 이식이 필요한 사람 증가, 만성 질환의 발생률이 증가합니다. 게다가 예측기간을 통하여 고령자 인구의 지속적인 증가와 제품기술의 진보 등의 요인이 메디컬 바이오닉스 및 중요 장기 서포트 시스템 세계 시장 성장을 가속할 것으로 예상됩니다.
그러나 의료 바이오닉스 및 장기 지원 시스템 시장 성장은 인공 장비 및 의료 바이오닉스의 높은 비용과 엄격한 규제 승인 절차에 의해 제약을 받을 것으로 예상됩니다. 게다가 앞으로 수년간 유리한 상환 정책, 관민들의 재정 지원, 유리한 의료 보험 제도가 의료 바이오닉스와 중요한 장기 지원 시스템 시장 성장을 지원할 것으로 보입니다.
목차
제1장 중요 장기 지원 시스템 및 메디컬 바이오닉스 세계 시장 : 소개
시장의 정의
시장 세분화
조사 스케줄
전제조건
제한 사항
제2장 VERIFIED MARKET RESEARCH의 조사 방법
데이터 마이닝
데이터의 삼각측량
상향식 접근
하향식 접근
조사의 흐름
업계 전문가의 주요 인사이트
데이터 소스
제3장 주요 요약
시장 개요
생태 매핑
절대 수익 기회
시장의 매력
중요 장기 서포트 시스템 및 메디컬 바이오닉스 세계 시장 :지역별 분석
중요 장기 서포트 시스템 및 메디컬 바이오닉스 세계 시장 : 제품별
중요 장기 서포트 시스템 및 메디컬 바이오닉스 세계 시장 : 최종 사용자별
향후 시장 기회
세계 시장 분할
제품 라이프 라인
제4장 중요 장기 서포트 시스템 및 메디컬 바이오닉스 세계 시장 전망
세계의 중요한 장기 서포트 시스템 및 메디컬 바이오닉스의 진화
성장 촉진요인
억제요인
기회
Porter's Five Forces 모델
밸류체인 분석
가격 분석
거시경제 분석
제5장 중요 장기 서포트 시스템 및 메디컬 바이오닉스 세계 시장 : 제품별
개요
바이탈 오르간 서포트 시스템
인공 심장
인공 신장
인공 간
기타
메디컬 바이오닉스
심장 바이오닉스
정형외과 바이오닉스
신경바이오닉스
기타
제6장 중요 장기 지원 시스템 및 메디컬 바이오닉스 세계 시장 : 최종 사용자별
개요
병원
외래수술센터(ASC)
기타
제7장 중요 장기 서포트 시스템 및 메디컬 바이오닉스 세계 시장 : 지역별
개요
북미
미국
캐나다
멕시코
유럽
독일
영국
프랑스
이탈리아
스페인
기타 유럽
아시아태평양
중국
일본
인도
기타 아시아태평양
라틴아메리카
브라질
아르헨티나
기타 라틴아메리카
중동 및 아프리카
아랍에미리트(UAE)
사우디아라비아
남아프리카
기타 중동 및 아프리카
제8장 중요 장기 서포트 시스템 및 메디컬 바이오닉스 세계 시장 : 경쟁 구도
개요
각사 시장 랭킹
주요 발전
기업의 지역별 실적
기업의 산업 발자국
ACE 매트릭스
제9장 기업 프로파일
Abiomed Inc
Abbott Laboratories(St. Jude Medical)
Asahi Kasei Corporation(Evaheart Medical USA Inc)
Baxter International Inc
Boston Scientific Corporation
Cochlear Ltd
Edwards Lifesciences Corporation
Jarvik Heart Inc
Medtronic Plc(Covidien Ltd)
Ossur Americas Inc
Second Sight Medical Products Inc
SynCardia Systems LLC
제10장 VERIFIED MARKET INTELLIGENCE
VERIFIED MARKET INTELLIGENCE에 대해
다이나믹한 데이터의 시각화
JHS
영문 목차
영문목차
Vital Organs Support Systems And Medical Bionics Market Size And Forecast
Vital Organs Support Systems And Medical Bionics Market size was valued at USD 46.43 Billion in 2024 and is projected to reach USD 96.66 Billion By 2031, growing at a CAGR of 9.60% from 2024 to 2031. This is brought on by a dearth of organ donors, an increase in organ transplant cases, a rise in the number of persons needing organ transplants due to hereditary or accidental disabilities, and a rise in the incidence of chronic diseases. The Global Vital Organs Support Systems And Medical Bionics Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.
Global Vital Organs Support Systems And Medical Bionics Market Definition
The artificial organs that make up the Organ Support System are created to mimic natural human organ function and are used to replace missing or damaged organs as well as support already functioning organs. These synthetic organs connect to living tissues and take the place of missing human organs.
The study of mechanical systems that duplicate organisms or specific living organism parts is known as medical bionics. Artificial organ support systems and medical bionics have the advantages of lessening the dependence on human donors, reducing the risk of organ rejection, and providing a more affordable treatment option for a variety of disorders. These advantages are anticipated to assist the market for medical bionics and systems to support essential organs as they expand.
What's inside a VMR industry report?
Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.
Global Vital Organs Support Systems And Medical Bionics Market Overview
In recent years, the global market for medical bionics and systems to support important organs has experienced significant expansion, and in the years to come, it is anticipated to continue to expand significantly both in terms of share and value. This is brought on by a dearth of organ donors, an increase in organ transplant cases, a rise in the number of persons needing organ transplants due to hereditary or accidental disabilities, and a rise in the incidence of chronic diseases. Additionally, throughout the forecast period, factors such as the continually growing elderly population, and advancements in product technologies are anticipated to boost the growth of the global market for medical bionics and vital organ support systems.
However, the market growth for medical bionics and vital organ support systems is anticipated to be constrained by the high cost of artificial devices and medical bionics as well as strict regulatory approval procedures. Moreover, in the coming years, favorable reimbursement policies, financial support from the public and private sectors, as well as favorable healthcare coverage schemes, will support the growth of the market for medical bionics and systems that support vital organs.
Global Vital Organs Support Systems And Medical Bionics Market Segmentation Analysis
The Global Vital Organs Support Systems And Medical Bionics Market is Segmented based on Product, End-User, And Geography.
Vital Organs Support Systems And Medical Bionics Market, By Product
Vital Organs Support Systems
Artificial Heart
Artificial Kidney
Artificial Liver
Others
Medical Bionics
Cardiac Bionics
Orthopedic Bionics
Neural Bionics
Others
Based on product, the market is segmented into vital organs support systems, and medical bionics. The vital organs support systems segment is segmented into artificial hearts, artificial livers, artificial kidneys, and others. The medical bionics market is classified into cardiac bionics, orthopedic bionics, neural bionics, and others. The vital organs support systems segment dominated the major market share of the vital organs support systems and medical bionics market. The growth of the segment is primarily attributed to a surge in patient acceptance that is poised to increase as more people become aware of medical bionics. Continuous advances in the fields of biomedical engineering and medical science are anticipated to increase the use rate of synthetic organs during the projected period.
Vital Organs Support Systems And Medical Bionics Market, By End-User
Hospitals
Ambulatory Surgical Centers
Others
Based on End-User, the market is segmented into Hospitals, Ambulatory Surgical Centers, and Others. the hospital segment dominated the major market share of the vital organs support systems and medical bionics market. The availability of numerous support departments, including MRI suites and ICUs, is responsible for the segment's expansion. Additionally, hospitals have more staff on hand to deal with complications. When complications arise during an operation, patients are frequently transferred from an ambulatory surgery center to the closest hospital, which will speed up the growth of the hospital segment throughout the forecast period.
Vital Organs Support Systems And Medical Bionics Market, By Geography
North America
Europe
Asia Pacific
Latin Ameria
Middle East & Africa
Based on Geography, the Global Vital Organs Support Systems And Medical Bionics Market is classified into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The market for medical bionics and systems to support key organs is dominated mostly by North America. This can be attributed to the rising prevalence of artificial organs in emerging markets, the existence of numerous key players participating in this market, the presence of a large number of players working in this industry, as well as the potential growth of healthcare spending. Furthermore, because cadaveric organ donation is so uncommon, artificial organ transplants are probably going to become more typical. An increasing number of new product approvals linked to the best use of innovative transplants are predicted to fuel market expansion over the forecast period. The industry is positioned to be driven by significant private-sector expenditures.
However, due to the rising prevalence of amputations from trauma and accidents, as well as brain injuries that cause visual and hearing loss, Asia-Pacific is predicted to have the fastest growth during the forecast period. Additionally, it is anticipated that demand for medical bionics and critical organ support systems will increase as a result of improved patient awareness and increased investment by major market players in developing economies, which is expected to fuel market growth throughout the forecast period for the market for these products.
Key Players
The "Global Vital Organs Support Systems And Medical Bionics Market" study report will provide valuable insight with an emphasis on the global market including some of the major players such as
Abiomed Inc., Abbott Laboratories (St. Jude Medical), Baxter International Inc., Second Sight Medical Products Inc, Boston Scientific Corporation, Cochlear Ltd, Edwards Lifesciences Corporation, Jarvik Heart Inc, Asahi Kasei Corporation (Evaheart Medical U.S.A. Inc), Medtronic Plc (Covidien Ltd), Ossur Americas Inc, SynCardia Systems LLC, and others.
Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.'
Key Developments
In 2020, Sonova Group unveiled its EXCITE-Pro platform, which was demonstrated by HANSATON, a manufacturer and provider of hearing systems.
Kindred Healthcare, LLC and Ekso Bionics Holdings, Inc. collaborated to pilot EksoNR, a robotic exoskeleton, in their long-term acute care hospitals in 2020.
In 2020, the Cobalt & Crome portfolio of Cardiac Resynchronization Therapy-Defibrillators (CRT-D) and Implantable Cardioverter-Defibrillators (ICD) from Medtronic Plc. received the Conformite Europeenne (CE) mark.
Ace Matrix Analysis
The Ace Matrix provided in the report would help to understand how the major key players involved in this industry are performing as we provide a ranking for these companies based on various factors such as service features & innovations, scalability, innovation of services, industry coverage, industry reach, and growth roadmap. Based on these factors, we rank the companies into four categories
Active, Cutting Edge, Emerging, and Innovators.
Market Attractiveness
The image of market attractiveness provided would further help to get information about the region that is majorly leading in the global Vital Organs Support Systems And Medical Bionics market. We cover the major impacting factors that are responsible for driving the industry growth in the given region.
Porter's Five Forces
The image provided would further help to get information about Porter's five forces framework providing a blueprint for understanding the behavior of competitors and a player's strategic positioning in the respective industry. Porter's five forces model can be used to assess the competitive landscape in the global Vital Organs Support Systems And Medical Bionics market, gauge the attractiveness of a certain sector, and assess investment possibilities.
TABLE OF CONTENTS
1 INTRODUCTION OF GLOBAL VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET
1.1 Market Definition
1.2 Market Segmentation
1.3 Research Timelines
1.4 Assumptions
1.5 Limitations
2 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH
2.1 Data Mining
2.2 Data Triangulation
2.3 Bottom-Up Approach
2.4 Top-Down Approach
2.5 Research Flow
2.6 Key Insights from Industry Experts
2.7 Data Sources
3 EXECUTIVE SUMMARY
3.1 Market Overview
3.2 Ecology Mapping
3.3 Absolute Market Opportunity
3.4 Market Attractiveness
3.5 Global Vital Organs Support Systems And Medical Bionics Market Geographical Analysis (CAGR %)
3.6 Global Vital Organs Support Systems And Medical Bionics Market, By Product (USD Million)
3.7 Global Vital Organs Support Systems And Medical Bionics Market, By End-User (USD Million)
3.8 Future Market Opportunities
3.9 Global Market Split
3.10 Product Life Line
4 GLOBAL VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET OUTLOOK
4.1 Global Vital Organs Support Systems And Medical Bionics Evolution
4.2 Drivers
4.2.1 Driver 1
4.2.2 Driver 2
4.3 Restraints
4.3.1 Restraint 1
4.3.2 Restraint 2
4.4 Opportunities
4.4.1 Opportunity 1
4.4.2 Opportunity 2
4.5 Porters Five Force Model
4.6 Value Chain Analysis
4.7 Pricing Analysis
4.8 Macroeconomic Analysis
5 GLOBAL VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY PRODUCT
5.1 Overview
5.2 Vital Organs Support Systems
5.2.1 Artificial Heart
5.2.2 Artificial Kidney
5.2.3 Artificial Liver
5.2.4 Others
5.3 Medical Bionics
5.3.1 Cardiac Bionics
5.3.2 Orthopedic Bionics
5.3.3 Neural Bionics
5.3.4 Others
6 GLOBAL VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY END-USER
6.1 Overview
6.2 Hospitals
6.3 Ambulatory Surgical Centers
6.4 Others
7 GLOBAL VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY GEOGRAPHY
7.1 Overview
7.2 North America
7.2.1 U.S.
7.2.2 Canada
7.2.3 Mexico
7.3 Europe
7.3.1 Germany
7.3.2 U.K.
7.3.3 France
7.3.4 Italy
7.3.5 Spain
7.3.6 Rest of Europe
7.4 Asia Pacific
7.4.1 China
7.4.2 Japan
7.4.3 India
7.4.4 Rest of Asia Pacific
7.5 Latin America
7.5.1 Brazil
7.5.2 Argentina
7.5.3 Rest of Latin America
7.6 Middle-East and Africa
7.6.1 UAE
7.6.2 Saudi Arabia
7.6.3 South Africa
7.6.4 Rest of Middle-East and Africa
8 GLOBAL VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET COMPETITIVE LANDSCAPE
8.1 Overview
8.2 Company Market Ranking
8.3 Key Developments
8.4 Company Regional Footprint
8.5 Company Industry Footprint
8.6 ACE Matrix
9 COMPANY PROFILES
9.1 Abiomed Inc
9.1.1 Company Overview
9.1.2 Company Insights
9.1.3 Product Benchmarking
9.1.4 Key Development
9.1.5 Winning Imperatives
9.1.6 Current Focus & Strategies
9.1.7 Threat from Competition
9.1.8 SWOT Analysis
9.2 Abbott Laboratories (St. Jude Medical)
9.2.1 Company Overview
9.2.2 Company Insights
9.2.3 Product Benchmarking
9.2.4 Key Development
9.2.5 Winning Imperatives
9.2.6 Current Focus & Strategies
9.2.7 Threat from Competition
9.2.8 SWOT Analysis
9.3 Asahi Kasei Corporation (Evaheart Medical U.S.A. Inc)
